Webcast

Prescient Therapeutics Investor Briefing – 12 November

November 12, 2020

Prescient Therapeutics Investor Briefing – 12 November

Prescient Therapeutics (ASX: PTX) Webcast Replay

Steven Yatomi-Clarke, CEO & MD of Prescient Therapeutics (ASX:PTX) provides an update on the company’s promising pipeline of cancer treatments, cell therapy enhancements and next-gen CAR-T ‘OmniCAR’,  which inserts PTX into the forefront of global CAR-T research

Recorded on 12 November 2020 at 11am (AEDT)

Join the next Prescient Therapeutics webcast

Speak to our Advisor team about this company

FEATURE SPEAKERS

STEVEN YATOMI-CLARKE

Chief Executive Officer & Managing Director - Prescient Therapeutics

Speak to our Advisor team about this company



By clicking submit, I agree to the terms of the Reach Markets Financial Services Guide that includes the Privacy Statement.